Proteinase-activated receptors (PARs) and the kidney

Drug Development Research

Volumn 60, Issue 1, 2003, Pages 36-42

  Hollenberg, Morley D ^a,b   Wijesuriya, Suranga J ^a   Gui, Yu ^a   Loutzenhiser, Rodger ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

EDHF; Kidney glomerular filtration; Proteinases; Renal blood flow; Thrombin; Trypsin

Indexed keywords

MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; PEPTIDE; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 4; SERYLLEUCYLISOLEUCYLGLYCYLARGINYLLEUCINAMINE; THREONYLPHENYLALANYLLEUCYLLEUCYLARGININAMINE; THROMBIN; TRYPSIN; UNCLASSIFIED DRUG;

CELLULAR DISTRIBUTION; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG SCREENING; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY BLOOD FLOW; KIDNEY BLOOD VESSEL; KIDNEY FUNCTION; KIDNEY PERFUSION; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW;

EID: 0041317112     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10318     Document Type: Review

References (37)

1. Arakawa K. 1996. Serine protease angiotensin II systems. J Hypertens Suppl 14:S3-S7.
2. Arakawa K, Maruta H. 1980. Ability of kallikrein to generate angiotensin II-like pressor substance and a proposed 'kinin-tensin enzyme system'. Nature 288:705-706.
3. Bautista DS, Denstedt J, Chambers AF, Harris JF. 1996. Low molecular weight variants of osteopontin generated by serine proteinases in urine of patients with kidney stones. J Cell Biochem 61:402-409.
4. Bertog M, Letz B, Kong W, Steinhoff M, Higgins MA, Bielfeld-Ackermann A, Fromter E, Bunnett NW, Korbmacher C. 1999. Basolateral proteinase-activated receptor (PAR-2) induces chloride secretion in M-1 mouse renal cortical collecting duct cells. J Physiol (Lond.) 521:3-17.
5. Böhm SK, Kong W, Bromme D, Smeekens SP, Anderson DC, Connolly A, Kahn M, Nelken NA, Coughlin SR, Payan DG, Bunnett NW. 1996. Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2. Biochem J 314:1009-1016.
6. Cumming AD, Walsh T, Wojtacha D, Fleming S, Thomson D, Jenkins DA. 1994. Expression of tissue kallikrein in human kidney. Clin Sci (Lond) 87:5-11.
7. Cunningham MA, Rondeau E, Chen X, Coughlin SR, Holdsworth SR, Tipping PG. 2000. Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis. J Exp Med 191:455-462.
8. D'Andrea MR, Derian CK, Letureq D, Baker SM, Brunmark A, Ling P, Darrow AL, Santulli RJ, Brass LF, Andrade-Gordon P. 1998. Characterization of protease-activated receptor-2 immunoreactivity in normal human tissues. J Histochem Cytochem 46:157-164.
9. Epstein M, Flamenbaum W, Loutzenhiser R. 1979/1980. Characterization of the renin-angiotensin system in the isolated perfused rat kidney. Renal Physiol Basel 2:244-256.
10. Gondo M, Maruta H, Arakawa K. 1989. Direct formation of angiotensin II without renin or converting enzyme in the ischemic dog heart. Jpn Heart J 30:219-229.
11. Grandaliano G, Monno R, Ranieri E, Valente M, Gesualdo L, Schena P. 1998. Glomerular tryptase and proteinase-activated receptor-2 (PAR-2) expression in IgA nephropathy (IgAN): a glomerular damage. J Am Soc Nephrol 9:495A.
12. Grandaliano G, Monno R, Ranieri E, Gesualdo L, Schena FP, Martino C, Ursi M. 2000. Regenerative and proinflammatory effects of thrombin on human proximal tubular cells. J Am Soc Nephrol 11:1016-1025.
13. Gui Y, Loutzenhiser R, Hollenberg MD. 2003. Bi-directional regulation of renal hemodynamics by activation of proteinase-activated receptors (PAR) 1 and 2 in the isolated perfused rat kidney. Am J Physiol Renal Physiol Mar 18. (epub ahead of print).
14. Hoogerwerf WA, Hellmich HL, Micci M, Winston JH, Zou L, Pasricha PJ. 2002. Molecular cloning of the rat proteinase-activated receptor 4 (PAR4). BMC Mol Biol 3:2.
15. Horl WH, Schafer RM, Scheidhauer K, Jochum M, Heidland A. 1984. Proteolytic activity in patients with hypercatabolic renal failure. Ad Med Exp Med Biol 167:405-416.
16. Ihara M, Urata H, Kinoshita A, Suzumiya J, Sasaguri M, Kikuchi M, Ideishi M, Arakawa K. 1999. Increased chinase-dependent angiotensin II formation in human atherosclerotic aorta. Hypertension 33:1399-1405.
17. Kahn ML, Zheng YW, Huang W, Bigornia V, Zeng D, Moff S, Farese RV Jr, Tam C, Coughlin SR. 1998. A dual thrombin receptor system for platelet activation. Nature 394:690-694.
18. Kauker ML, Nasjletti A. 1986. Segmental nephron function in rats treated with aprotinin, an inhibitor of kallikrein. J Pharmacol Exp Ther 238:155-158.
19. Madeddu P, Oppes M, Soro A, Dessi-Fulgheri P, Glorioso N, Manunta F, Rubatti S, Rappelli A. 1987. The effects of aprotinin, a glandular kallikrein inhibitor, on renin release and urinary sodium excretion in mild essential hypertensives. Agents Actions 22(Suppl):373-380.
20. McGuire JJ, Hollenberg MD, Andrade-Gordon P, Triggle CR. 2002. Multiple mechanisms of vascular smooth muscle relaxation by the activation of proteinase-activated receptor 2 in mouse mesenteric arterioles. Br J Pharmacol 135:155-169.
21. Muramatsu I, Laniyonu AA, Moore GJ, Hollenberg MD. 1992. Vascular actions of thrombin receptor peptide. Can J Physiol Pharmacol 70:996-1103.
22. Naicker S, Naidoo S, Ramsaroop R, Moodley D, Bhoola K. 1999. Tissue kallikrein and kinins in renal disease. Immunopharmacology 44:183-192.
23. Nystedt S, Emilsson K, Wahlestedt C, Sundelin J. 1994. Molecular cloning of a potential proteinase activated receptor. Proc Natl Acad Sci USA 91:9208-9212.
24. Petraki CD, Karavana VN, Skoufogiannis PT, Little SP, Howarth DJ, Yousef GM, Diamandis EP. 2001. The spectrum of human kallikrein 6 (zyme/protease M/neurosin) expression in human tissues as assessed by immunohistochemistry. J Histochem Cytochem 49:1431-1441,
25. Rasmussen UB, Vouret-Craviari V, Jallat S, Schlesinger Y, Pages G, Pavirani A, Lecocq JP, Pouyssegur J, VanObberghen-Schilling E. 1991. cDNA cloning and expression of a hamster alpha-thrombin receptor coupled to Ca2+ mobilization. FEBS Lett 288:123-128.
26. Rocha e Silva M. 1936. Liberation de l'histamine par la perfusion du poumon de cobaye au moyen de la trypsine. CR Soc Biol (Paris) 130:186-188,
27. Rocha e Silva M, Beraldo WT, Rosenfeld G. 1949. Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and by trypsin. Am J Physiol 156:261-273.
28. Saifeddine M, Al-Ani B, Sandhu S, Wijesuriya SJ, Hollenberg MD. 2001. Contractile actions of proteinase-activated receptor-derived polypeptides in guinea-pig gastric and lung parenchymal strips: evidence for distinct receptor systems. Br J Pharmacol 132:556-566.
29. Trottier G, Triggle CR, O'Neill SK, Loutzenhiser R. 1998. Cyclic GMP-dependent and cyclic GMP-independent actions of nitric oxide on the renal afferent arteriole. Br J Pharmacol 126:563-569.
30. Trottier G, Hollenberg M, Wang X, Gui Y, Loutzenhiser C, Loutzenhiser R. 2002. PAR-2 elicits afferent arteriolar vasodilation by NO-dependent and NO-independent actions. Am J Physiol 282:F891-F897.
31. Urata H, Kinoshita A, Misono KS, Bumpus FM, Husain A. 1990. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem 265:22348-22357.
32. Urata H, Boehm KD, Philip A, Kinoshita A, Gabrovsek J, Bumpus FM, Husain A. 1993. Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart. J Clin Invest 91:1269-1281.
33. Wassdal I, Hull R, Gerskowithch VP, Berg T. 1995. Kallikrein rK10-induced kinin-independent direct activation of NO-formation and relaxation of rat isolated aortic rings. Br J Pharmacol 155:356-360.
34. 2): renal distribution and detection of activated receptors. MSc Thesis, University of Calgary, Calgary, Alberta, Canada.
35. Williams JC, Falcone RC, Do MLT, Dinstrom DD. 1991. Acute blood pressure effects of selected serine proteases in normotensive rats and dogs. Pharmacology 43:199-209.
36. Xu WF, Andersen H, Whitmore TE, Presnell SR, Yee DP, Ching A, Gilbert T, Davie EW, Foster DC. 1998. Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci U S A 95:6642-6646.
37. Xu Y, Zacharias U, Peraldi M-N, He C-J, Lu C, Saer J-D, Brass, LF, Rondeau E. 1995. Constitutive expression and modulation of the functional thrombin receptor in the human kidney. Am J Pathol 146:101-110.